Monthly Archives: June 2011


Steve “Da Yooper” Bashaw passes peacefully at 59

Stephen was born March 12, 1952 in Laurium, MI to Florence (Paquin) and the late George Bashaw. He graduated from Lake Linden-Hubbell High School, class of 1970. Following high school, he served his country in the United States Marine Corp. He was honorably discharged in 1973 after serving in Vietnam.

By |2019-10-15T09:52:27-04:00June 1st, 2011|In Memoriam, News|

Swiss are back at it with 8th annual meeting

Approximately 90 GIST patients, relatives, GIST experts, interested professionals, physicians and representatives of the pharmaceutical industry gathered in Zurich on April 8, 2011 for the eighth meeting of the Swiss GIST group in the Restaurant Au Premier at Zurich Main Station (HB Zürich).

By |2019-12-26T12:42:13-05:00June 1st, 2011|News|

State of the GIST Community Part 3: What do we know about mutational testing?

As of May 1, 2011, the LRG patient registry only received 377 reports of mutations out of 1,327 patients, which only represents 28 percent of the entire registry. Part of this may be related to the fact that mutational testing is not common practice at diagnosis.

By |2019-04-05T09:20:33-04:00June 1st, 2011|Mutational Testing, News|

Alianza GIST meets for second time in Brazil

At the end of 2009, The Life Raft Group proudly announced the foundation of an important initiative, the Latin American GIST Coalition, now called Alianza GIST. Currently comprised of twelve countries, this group of patient advocates from across Latin America has formed a partnership dedicated to improving the survival and lives of GIST patients in Latin America.

By |2019-12-26T12:38:38-05:00June 1st, 2011|News|

Mutational Testing & Survival: Where We Stand

Only six percent of GIST patients in the United States take advantage of testing that could be used to individualize their treatment according to a new article in the Annals of Oncology. Dr. Peter Pisters of MD Anderson Cancer Center in Houston, Texas and his colleagues reported results of the GIST reGISTry, a Novartis Pharmaceuticals-supported registry of 882 GIST patients in the United States.

By |2019-04-05T09:52:42-04:00June 1st, 2011|Mutational Testing, News, Survival Strategies|
Go to Top